Chapter/Section Purchase

1 Study Coverage
1.1 mRNA Vaccines & Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global mRNA Vaccines & Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global mRNA Vaccines & Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global mRNA Vaccines & Therapeutics Sales by Region
2.4.1 Global mRNA Vaccines & Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales mRNA Vaccines & Therapeutics by Region (2023-2028)
2.5 Global mRNA Vaccines & Therapeutics Revenue by Region
2.5.1 Global mRNA Vaccines & Therapeutics Revenue by Region (2017-2022)
2.5.2 Global mRNA Vaccines & Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturers
3.1.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of mRNA Vaccines & Therapeutics in 2021
3.2 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers
3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by mRNA Vaccines & Therapeutics Revenue in 2021
3.3 Global mRNA Vaccines & Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global mRNA Vaccines & Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global mRNA Vaccines & Therapeutics Sales by Type
4.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global mRNA Vaccines & Therapeutics Revenue by Type
4.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global mRNA Vaccines & Therapeutics Price by Type
4.3.1 Global mRNA Vaccines & Therapeutics Price by Type (2017-2022)
4.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global mRNA Vaccines & Therapeutics Sales by Application
5.1.1 Global mRNA Vaccines & Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global mRNA Vaccines & Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global mRNA Vaccines & Therapeutics Revenue by Application
5.2.1 Global mRNA Vaccines & Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global mRNA Vaccines & Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global mRNA Vaccines & Therapeutics Price by Application
5.3.1 Global mRNA Vaccines & Therapeutics Price by Application (2017-2022)
5.3.2 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America mRNA Vaccines & Therapeutics Market Size by Type
6.1.1 North America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
6.1.2 North America mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
6.2 North America mRNA Vaccines & Therapeutics Market Size by Application
6.2.1 North America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
6.2.2 North America mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
6.3 North America mRNA Vaccines & Therapeutics Market Size by Country
6.3.1 North America mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
6.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe mRNA Vaccines & Therapeutics Market Size by Type
7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
7.2 Europe mRNA Vaccines & Therapeutics Market Size by Application
7.2.1 Europe mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
7.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
7.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
7.3.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
7.3.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Type
8.1.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Application
8.2.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific mRNA Vaccines & Therapeutics Market Size by Region
8.3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America mRNA Vaccines & Therapeutics Market Size by Type
9.1.1 Latin America mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
9.2 Latin America mRNA Vaccines & Therapeutics Market Size by Application
9.2.1 Latin America mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
9.3 Latin America mRNA Vaccines & Therapeutics Market Size by Country
9.3.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Type
10.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Application
10.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country
10.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Corporation Information
11.1.2 Moderna Therapeutics Overview
11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Corporation Information
11.3.2 Translate Bio Overview
11.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Corporation Information
11.4.2 BioNTech Overview
11.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BioNTech mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Corporation Information
11.5.2 Sangamo Therapeutics Overview
11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Corporation Information
11.6.2 Argos Therapeutics Overview
11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Corporation Information
11.7.2 In-Cell-Art Overview
11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Corporation Information
11.8.2 eTheRNA Overview
11.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Corporation Information
11.9.2 Ethris Overview
11.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ethris mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Corporation Information
11.10.2 Tiba Biotechnology Overview
11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tiba Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 mRNA Vaccines & Therapeutics Industry Chain Analysis
12.2 mRNA Vaccines & Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 mRNA Vaccines & Therapeutics Production Mode & Process
12.4 mRNA Vaccines & Therapeutics Sales and Marketing
12.4.1 mRNA Vaccines & Therapeutics Sales Channels
12.4.2 mRNA Vaccines & Therapeutics Distributors
12.5 mRNA Vaccines & Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 mRNA Vaccines & Therapeutics Industry Trends
13.2 mRNA Vaccines & Therapeutics Market Drivers
13.3 mRNA Vaccines & Therapeutics Market Challenges
13.4 mRNA Vaccines & Therapeutics Market Restraints
14 Key Findings in The Global mRNA Vaccines & Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer